Who measures the Holy Dread?BMJ 2005; 331 doi: https://doi.org/10.1136/bmj.331.7507.57-a (Published 30 June 2005) Cite this as: BMJ 2005;331:57
- Kevin Barraclough, general practitioner
- Painswick, Gloucestershire
If you tell patients that a drug is shown in a trial to reduce their absolute risk by 0.2% per year they usually don't want it. They weigh the marginal absolute benefit against the harm of being “medicalised,” and they decline. The opinion forming “experts” who ran the trial take a different view. The experts demonstrate the relative risk reduction with bar charts at a string of lucrative international conferences. They sit on the guidelines …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial